Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program

OBJECTIVE: To evaluate effects of the dual sodium–glucose cotransporter (SGLT) 1 and SGLT2 inhibitor sotagliflozin in combination with insulin on glucose time in range (TIR) and glucose excursions, postprandial glucose (PPG), and other glycemic metrics in adults with type 1 diabetes using masked con...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Diabetes Care
Main Authors: Danne, Thomas, Cariou, Bertrand, Buse, John B., Garg, Satish K., Rosenstock, Julio, Banks, Phillip, Kushner, Jake A., McGuire, Darren K., Peters, Anne L., Sawhney, Sangeeta, Strumph, Paul
פורמט: Artigo
שפה:Inglês
יצא לאור: American Diabetes Association 2019
נושאים:
Emerging Therapies: Drugs and Regimens
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905498/
https://ncbi.nlm.nih.gov/pubmed/30833371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-2149
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים